ARTICLE | Finance
Mega-round for Alentis spotlights French firm’s investment style
By Jeff Cranmer, Executive Editor
November 23, 2024 2:54 AM UTC
Jeito’s latest investment, co-leading Alentis’ $181 million series D round, shows the firm executing on its mission statement four years after debuting its inaugural €534 million fund and having notched a trio of exits.
It’s also the third time Jeito Capital has invested in Alentis Therapeutics AG, as the firm follows its playbook: continuing to lead or co-lead rounds, guiding a company through its earliest phases with an eye toward going to market. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654165/latest-jeito-bet-positions-european-vc-for-fourth-exit